More answers about prophylactic mastectomy

William C Wood. Ann Surg Oncol. 2007 Dec.

. 2007 Dec;14(12):3283-4.

doi: 10.1245/s10434-007-9507-4. Epub 2007 Sep 25.

No abstract available

Comment on

Prophylactic mastectomy in BRCA1/2 mutation carriers and women at risk of hereditary breast cancer: long-term experiences at the Rotterdam Family Cancer Clinic.
Heemskerk-Gerritsen BA, Brekelmans CT, Menke-Pluymers MB, van Geel AN, Tilanus-Linthorst MM, Bartels CC, Tan M, Meijers-Heijboer HE, Klijn JG, Seynaeve C. Heemskerk-Gerritsen BA, et al. Ann Surg Oncol. 2007 Dec;14(12):3335-44. doi: 10.1245/s10434-007-9449-x. Epub 2007 May 31. Ann Surg Oncol. 2007. PMID: 17541692 Free PMC article.

1. Heemskerk-Gerritsen, Brekelmans, Menke-Pluijmers, et al. Prophylactic mastectomy in BRCA1/2 mutation carriers and women at risk of hereditary breast cancer: long-term experiences at the Rotterdam Family Cancer Clinic. Ann Surg Oncol 2007; 14: doi:10.1245/s10434-007-9449-x [Online May 31, 2007] - PMC - PubMed
1. Kuhl C, Schrading S, Leutner CC, et al. Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk of breast cancer. J Clin Oncol 2005; 23:8469–8476 - DOI - PubMed
1. Eisen A, Lubinski J, Klijn J, et al. Breast cancer risk following bilateral oophorectomy in BRCA1 and BRCA2 mutation carriers: an international case control study. J Clin Oncol 2005; 23:7491–7496 - DOI - PubMed
1. Gronwald J, Tung N, Foulkes WD, et al. Tamoxifen and contralateral breast cancer in BRCA1 and BRCA2 carriers: an update. Int J Cancer 2006; 118:2281–2284 - DOI - PubMed